PP
BIND

Palladium Partners’s BIND THERAPEUTICS INC BIND Stock Holding History

Palladium Partners’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,600
Closed -$43K – 533
2014
Q1 		$43K Buy
+3,600
New +$47K ﹤0.01% 357

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Palladium Partners's BIND Position: Q2 2014 in Review

Palladium Partners sold out of BIND THERAPEUTICS INC (BIND) in Q2 2014, closing a stake of 3,600 shares — an estimated $43K sold.

Palladium Partners first reported a position in BIND in Q1 2014 and held it in 1 quarter. The position peaked at $43K in Q1 2014. 43 funds tracked by Wall St. Rank hold BIND as of Q2 2014.

  • Palladium Partners reported no remaining BIND THERAPEUTICS INC position as of Q2 2014 after selling out during the quarter.
  • Palladium Partners sold 3,600 BIND THERAPEUTICS INC shares in Q2 2014, an estimated $43K.
  • Palladium Partners first reported a position in BIND THERAPEUTICS INC in Q1 2014 and held it in 1 quarter.
  • Palladium Partners's BIND THERAPEUTICS INC position peaked at $43K in Q1 2014.
  • 43 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2014.

Based on Palladium Partners's 13F filing for Q2 2014, filed 1 Aug 2014.